#BEGIN_DRUGCARD DB02078

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
44842

# Chemical_Formula:
C8H18O4

# Chemical_IUPAC_Name:
2,5,8,11-tetraoxadodecane

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
1-Methoxy-2-[2-(2-Methoxy-Ethoxy]-Ethane

# HET_ID:
PG5

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C8H18O4/c1-9-3-5-11-7-8-12-6-4-10-2/h3-8H2,1-2H3

# InChI_Key:
InChIKey=YFNKIDBQEZZDLK-UHFFFAOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
2078

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
178.2261

# Molecular_Weight_Mono:
178.120509064

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1D1J

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-0.09

# Predicted_LogS:
-1

# Predicted_Water_Solubility:
1.67e+01 g/l

# Primary_Accession_No:
DB02078

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
8189

# PubChem_Substance_ID:
46505275

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02565

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
COCCOCCOCCOC

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:20:46 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_10_Cellular_Location:
Not Available

# Drug_Target_10_Chromosome_Location:
Not Available

# Drug_Target_10_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_10_Essentiality:
Essential

# Drug_Target_10_GenAtlas_ID:
Not Available

# Drug_Target_10_GenBank_ID_Gene:
AE016879

# Drug_Target_10_GenBank_ID_Protein:
30253517

# Drug_Target_10_GeneCard_ID:
tkt-2

# Drug_Target_10_Gene_Name:
tkt2

# Drug_Target_10_Gene_Sequence:
>1341 bp
TTGGAAAACATCTCTGATTTATGGAACAGCGCCTTAAAAGAACTCGAAAAAAAGGTCAGT
AAACCAAGTTATGAAACATGGTTAAAATCAACAACCGCACATAATTTAAAGAAAGATGTA
TTAACAATTACGGCTCCAAATGAATTCGCCCGTGATTGGTTAGAATCTCATTATTCAGAG
CTAATTTCGGAAACACTTTATGATTTAACGGGGGCAAAATTAGCTATTCGCTTTATTATT
CCCCAAAGTCAAGCTGAAGAGGAGATTGATCTTCCTCCTGCTAAACCAAATGCAGCACAA
GATGATTCTAATCATTTACCACAGAGTATGCTAAACCCAAAATATACGTTTGATACATTT
GTTATTGGCTCTGGTAACCGTTTTGCTCACGCTGCTTCATTGGCCGTAGCCGAAGCGCCA
GCTAAAGCATATAATCCCCTCTTTATTTATGGGGGAGTTGGACTTGGAAAAACCCATTTA
ATGCATGCAATTGGCCATTATGTAATTGAACATAACCCAAATGCCAAAGTTGTATATTTA
TCATCAGAAAAATTTACAAATGAATTCATTAATTCTATTCGTGATAATAAAGCGGTCGAT
TTTCGTAATAAATACCGCAATGTAGATGTTTTATTGATAGATGATATTCAATTTTTAGCG
GGAAAAGAACAAACTCAAGAAGAGTTTTTCCATACATTCAATGCATTACACGAAGAAAGT
AAACAAATTGTAATTTCCAGTGATCGGCCACCAAAAGAAATTCCAACTTTAGAAGATCGT
CTTCGTTCTCGCTTTGAATGGGGACTCATTACGGATATTACGCCACCAGATTTAGAAACA
CGAATTGCGATTTTACGTAAAAAGGCAAAGGCTGAAGGACTTGATATACCAAATGAGGTC
ATGCTTTATATCGCAAATCAAATCGATTCAAATATTCGTGAACTAGAAGGTGCACTCATC
CGCGTTGTAGCTTATTCATCTTTAATTAACAAGGATATTAATGCTGATTTAGCAGCTGAA
GCACTTAAAGATATTATTCCAAATTCTAAACCAAAAATTATCTCCATTTATGATATTCAA
AAAGCTGTTGGAGATGTTTATCAAGTAAAATTAGAAGATTTCAAGGCGAAAAAGCGCACA
AAGTCAGTTGCCTTTCCTCGCCAAATTGCAATGTATTTGTCACGCGAACTGACAGATTCC
TCCTTACCTAAAATAGGTGAAGAATTTGGTGGACGTGATCATACAACCGTTATCCATGCC
CATGAAAAAATTTCTAAGCTACTTAAGACGGATACGCAATTACAAAAACAAGTTGAAGAA
ATTAACGATATTTTAAAGTAG

# Drug_Target_10_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_10_General_References:
12721629	Read TD, Peterson SN, Tourasse N, Baillie LW, Paulsen IT, Nelson KE, Tettelin H, Fouts DE, Eisen JA, Gill SR, Holtzapple EK, Okstad OA, Helgason E, Rilstone J, Wu M, Kolonay JF, Beanan MJ, Dodson RJ, Brinkac LM, Gwinn M, DeBoy RT, Madpu R, Daugherty SC, Durkin AS, Haft DH, Nelson WC, Peterson JD, Pop M, Khouri HM, Radune D, Benton JL, Mahamoud Y, Jiang L, Hance IR, Weidman JF, Berry KJ, Plaut RD, Wolf AM, Watkins KL, Nierman WC, Hazen A, Cline R, Redmond C, Thwaite JE, White O, Salzberg SL, Thomason B, Friedlander AM, Koehler TM, Hanna PC, Kolsto AB, Fraser CM: The genome sequence of Bacillus anthracis Ames and comparison to closely related bacteria. Nature. 2003 May 1;423(6935):81-6.

# Drug_Target_10_HGNC_ID:
Not Available

# Drug_Target_10_HPRD_ID:
Not Available

# Drug_Target_10_ID:
6810

# Drug_Target_10_Locus:
Not Available

# Drug_Target_10_Molecular_Weight:
72408.7

# Drug_Target_10_Name:
Transketolase

# Drug_Target_10_Number_of_Residues:
666

# Drug_Target_10_PDB_ID:
Not Available

# Drug_Target_10_Pathway:
Not Available

# Drug_Target_10_Pfam_Domain_Function:
PF00456	Transketolase_N
PF02779	Transket_pyr
PF02780	Transketolase_C

# Drug_Target_10_Protein_Sequence:
>Transketolase
MSHSIEQLSINTIRTLSIDAIEKANSGHPGMPMGAAPMAYTLWTQFMKHNPNNPTWFNRD
RFVLSAGHGSMLLYSLLHLSGYDVTMDDLKNFRQWGSKTPGHPEYGHTAGVDATTGPLGQ
GIATAVGMAMAERHLAAKYNRDAYNIVDHYTYAICGDGDLMEGVSAEASSLAAHLQLGRL
VVLYDSNDISLDGDLNRSFSESVEDRYKAYGWQVIRVEDGNDIEAIAKAIEEAKADEKRP
TLIEVRTTIGFGSPNKSGKSASHGSPLGVEETKLTKEAYAWTAEQDFHVAEEVYENFRKT
VQDVGETAQAEWNTMLGEYAQAYPELANELQAAMNGLLPEGWEQNLPTYELGSKAATRNS
SGAVINAIAESVPSFFGGSADLAGSNKTYMNNEKDFTRDDYSGKNIWYGVREFAMGAAMN
GIALHGGLKTYGGTFFVFSDYLRPAIRLAALMQLPVTYVFTHDSIAVGEDGPTHEPIEQL
AALRAMPNVSVIRPADGNESVAAWRLALESTNKPTALVLTRQDLPTLEGAKDDTYEKVAK
GAYVVSASKKETADVILLATGSEVSLAVEAQKALAVDGVDASVVSMPSMDRFEAQTAEYK
ESVLPKAVTKRFAIEMGATFGWHRYVGLEGDVLGIDTFGASAPGEKIMEEYGFTVENVVR
KVKEML

# Drug_Target_10_Reaction:
Not Available

# Drug_Target_10_Signals:
None

# Drug_Target_10_Specific_Function:
Not Available

# Drug_Target_10_SwissProt_ID:
Q81Y15

# Drug_Target_10_SwissProt_Name:
Q81Y15_BACAN

# Drug_Target_10_Synonyms:
Not Available

# Drug_Target_10_Theoretical_pI:
4.71

# Drug_Target_10_Transmembrane_Regions:
None

# Drug_Target_1_Cellular_Location:
Cell outer membrane
lipid-anchor

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
AE005674

# Drug_Target_1_GenBank_ID_Protein:
Not Available

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
lolB

# Drug_Target_1_Gene_Sequence:
>624 bp
TTATTTCACTATCCAGTTATCCATTTTTAACTTGATGCGTTGACCACCGTCGGTGAGTTC
CATATTGGCTGGCATCGCAGGTTGCGTTTTGGTGTCATAACCACCATAAACAACCTTCCA
GTTTTTGCCATTCTGGCTGTAGGTAATTTCGCTCAGGCGGTACTGGTCGTCCAGTTTGTA
GTCGGTTGCATCACCCGGTAAACCTAAAATCCACTGGCGCAAGCTGTTGAGCGGAATTGG
CATTCCGGTCAATTTGCCAATCATCTCTTCGGCGTCATCGGCGGTATAACGCTGACCTTT
ATTGTCGACCAACTGCACGTTACCCGGTTGAGCATTCAGCTCCAGTTCCGTGCTGCCCAA
TGGGTTAGTGAGCAGCAGACGGTAGCGATCCTGGCCGGTTTGCTGCCAGAAAAAGCGGGC
GTACACTTTTTGTTGGTCAGAAATATAAGCGAACGCGCCGCGAGTCTGATACTGATTAAG
ATTGCGCACGTCTTGCTGATGCTGACGCCATTGTGGCGAATCCGGGCTTTTGCCAGGACC
TTTGGGCGTGGTAACGGAACAGGCAGTGAGCACAAGAGCAGCCAGCGGTAGCAGGCGGAT
AAGACGAAAATCGGGCAGGGGCAT

# Drug_Target_1_General_Function:
Cell wall/membrane/envelope biogenesis

# Drug_Target_1_General_References:
12384590	Jin Q, Yuan Z, Xu J, Wang Y, Shen Y, Lu W, Wang J, Liu H, Yang J, Yang F, Zhang X, Zhang J, Yang G, Wu H, Qu D, Dong J, Sun L, Xue Y, Zhao A, Gao Y, Zhu J, Kan B, Ding K, Chen S, Cheng H, Yao Z, He B, Chen R, Ma D, Qiang B, Wen Y, Hou Y, Yu J: Genome sequence of Shigella flexneri 2a: insights into pathogenicity through comparison with genomes of Escherichia coli K12 and O157. Nucleic Acids Res. 2002 Oct 15;30(20):4432-41.
12704152	Wei J, Goldberg MB, Burland V, Venkatesan MM, Deng W, Fournier G, Mayhew GF, Plunkett G 3rd, Rose DJ, Darling A, Mau B, Perna NT, Payne SM, Runyen-Janecky LJ, Zhou S, Schwartz DC, Blattner FR: Complete genome sequence and comparative genomics of Shigella flexneri serotype 2a strain 2457T. Infect Immun. 2003 May;71(5):2775-86.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2704

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
23551

# Drug_Target_1_Name:
Outer-membrane lipoprotein lolB

# Drug_Target_1_Number_of_Residues:
207

# Drug_Target_1_PDB_ID:
1IWN

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF03550	LolB

# Drug_Target_1_Protein_Sequence:
>Outer-membrane lipoprotein lolB precursor
MPLPDFRLIRLLPLAALVLTACSVTTPKGPGKSPDSPQWRQHQQDVRNLNQYQTRGAFAY
ISDQQKVYARFFWQQTGQDRYRLLLTNPLGSTELELNAQPGNVQLVDNKGQRYTADDAEE
MIGKLTGMPIPLNSLRQWILGLPGDATDYKLDDQYRLSEITYSQNGKNWKVVYGGYDTKT
QPAMPANMELTDGGQRIKLKMDNWIVK

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
1-21

# Drug_Target_1_Specific_Function:
Plays a critical role in the incorporation of lipoproteins in the outer membrane after they are released by the lolA protein

# Drug_Target_1_SwissProt_ID:
P61322

# Drug_Target_1_SwissProt_Name:
LOLB_SHIFL

# Drug_Target_1_Synonyms:
Outer-membrane lipoprotein lolB precursor

# Drug_Target_1_Theoretical_pI:
9.19

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Cytoplasm, cytoskeleton

# Drug_Target_2_Chromosome_Location:
3

# Drug_Target_2_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
L10678

# Drug_Target_2_GenBank_ID_Protein:
190388

# Drug_Target_2_GeneCard_ID:
PFN2

# Drug_Target_2_Gene_Name:
PFN2

# Drug_Target_2_Gene_Sequence:
>423 bp
ATGGCCGGTTGGCAGAGCTACGTGGATAACCTGATGTGCGATGGCTGCTGCCAGGAGGCC
GCCATTGTCGGCTACTGCGACGCCAAATACGTCTGGGCAGCCACGGCCGGGGGCGTCTTT
CAGAGCATTACGCCAATAGAAATAGATATGATTGTAGGAAAAGACCGGGAAGGTTTCTTT
ACCAACGGTTTGACTCTTGGCGCGAAGAAATGCTCAGTGATCAGAGATAGTCTATACGTC
GATGGTGACTGCACAATGGACATCCGGACAAAGAGTCAAGGTGGGGAGCCAACATACAAT
GTGGCTGTCGGCAGAGCTGGTAGAGCATTGGTTATAGTCATGGGAAAGGAAGGTGTCCAC
GGAGGCACACTTAACAAGAAAGCATATGAACTCGCTTTATACCTGAGGAGGTCTGATGTG
TAA

# Drug_Target_2_General_Function:
Involved in actin binding

# Drug_Target_2_General_References:
10600384	Nodelman IM, Bowman GD, Lindberg U, Schutt CE: X-ray structure determination of human profilin II: A comparative structural analysis of human profilins. J Mol Biol. 1999 Dec 17;294(5):1271-85.
11027290	Lambrechts A, Braun A, Jonckheere V, Aszodi A, Lanier LM, Robbens J, Van Colen I, Vandekerckhove J, Fassler R, Ampe C: Profilin II is alternatively spliced, resulting in profilin isoforms that are differentially expressed and have distinct biochemical properties. Mol Cell Biol. 2000 Nov;20(21):8209-19.
15489334	Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7.
18083107	Rikova K, Guo A, Zeng Q, Possemato A, Yu J, Haack H, Nardone J, Lee K, Reeves C, Li Y, Hu Y, Tan Z, Stokes M, Sullivan L, Mitchell J, Wetzel R, Macneill J, Ren JM, Yuan J, Bakalarski CE, Villen J, Kornhauser JM, Smith B, Li D, Zhou X, Gygi SP, Gu TL, Polakiewicz RD, Rush J, Comb MJ: Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell. 2007 Dec 14;131(6):1190-203.
7758455	Gieselmann R, Kwiatkowski DJ, Janmey PA, Witke W: Distinct biochemical characteristics of the two human profilin isoforms. Eur J Biochem. 1995 May 1;229(3):621-8.
8365484	Honore B, Madsen P, Andersen AH, Leffers H: Cloning and expression of a novel human profilin variant, profilin II. FEBS Lett. 1993 Sep 13;330(2):151-5.

# Drug_Target_2_HGNC_ID:
GNC:8882

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
6804

# Drug_Target_2_Locus:
3q25.1-q25.2

# Drug_Target_2_Molecular_Weight:
15046.2

# Drug_Target_2_Name:
Profilin-2

# Drug_Target_2_Number_of_Residues:
140

# Drug_Target_2_PDB_ID:
1D1J

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00235	Profilin

# Drug_Target_2_Protein_Sequence:
>Profilin-2
MAGWQSYVDNLMCDGCCQEAAIVGYCDAKYVWAATAGGVFQSITPIEIDMIVGKDREGFF
TNGLTLGAKKCSVIRDSLYVDGDCTMDIRTKSQGGEPTYNVAVGRAGRVLVFVMGKEGVH
GGGLNKKAYSMAKYLRDSGF

# Drug_Target_2_Reaction:
Not Available

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Binds to actin and affects the structure of the cytoskeleton. At high concentrations, profilin prevents the polymerization of actin, whereas it enhances it at low concentrations. By binding to PIP2, it inhibits the formation of IP3 and DG

# Drug_Target_2_SwissProt_ID:
P35080

# Drug_Target_2_SwissProt_Name:
PROF2_HUMAN

# Drug_Target_2_Synonyms:
Profilin II

# Drug_Target_2_Theoretical_pI:
7.04

# Drug_Target_2_Transmembrane_Regions:
None

# Drug_Target_3_Cellular_Location:
Cell outer membrane

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_3_Essentiality:
Essential

# Drug_Target_3_GenAtlas_ID:
Not Available

# Drug_Target_3_GenBank_ID_Gene:
M77237

# Drug_Target_3_GenBank_ID_Protein:
290462

# Drug_Target_3_GeneCard_ID:
lolB

# Drug_Target_3_Gene_Name:
lolB

# Drug_Target_3_Gene_Sequence:
>69 bp
ATGTCTGCGGGAAATAATACCAACGTTGATAGGGTTAGTCTGCTTGCATCATACATACAG
GATGCGTAA

# Drug_Target_3_General_Function:
Cell wall/membrane/envelope biogenesis

# Drug_Target_3_General_References:
11673422	Tanaka K, Matsuyama SI, Tokuda H: Deletion of lolB, encoding an outer membrane lipoprotein, is lethal for Escherichia coli and causes accumulation of lipoprotein localization intermediates in the periplasm. J Bacteriol. 2001 Nov;183(22):6538-42.
12839983	Takeda K, Miyatake H, Yokota N, Matsuyama S, Tokuda H, Miki K: Crystal structures of bacterial lipoprotein localization factors, LolA and LolB. EMBO J. 2003 Jul 1;22(13):3199-209.
1427085	Ikemi M, Murakami K, Hashimoto M, Murooka Y: Cloning and characterization of genes involved in the biosynthesis of delta-aminolevulinic acid in Escherichia coli. Gene. 1992 Nov 2;121(1):127-32.
16738553	Hayashi K, Morooka N, Yamamoto Y, Fujita K, Isono K, Choi S, Ohtsubo E, Baba T, Wanner BL, Mori H, Horiuchi T: Highly accurate genome sequences of Escherichia coli K-12 strains MG1655 and W3110. Mol Syst Biol. 2006;2:2006.0007. Epub 2006 Feb 21.
7543480	Strohmaier H, Remler P, Renner W, Hogenauer G: Expression of genes kdsA and kdsB involved in 3-deoxy-D-manno-octulosonic acid metabolism and biosynthesis of enterobacterial lipopolysaccharide is growth phase regulated primarily at the transcriptional level in Escherichia coli K-12. J Bacteriol. 1995 Aug;177(15):4488-500.
7679718	Post DA, Hove-Jensen B, Switzer RL: Characterization of the hemA-prs region of the Escherichia coli and Salmonella typhimurium chromosomes: identification of two open reading frames and implications for prs expression. J Gen Microbiol. 1993 Feb;139(2):259-66.
8905232	Oshima T, Aiba H, Baba T, Fujita K, Hayashi K, Honjo A, Ikemoto K, Inada T, Itoh T, Kajihara M, Kanai K, Kashimoto K, Kimura S, Kitagawa M, Makino K, Masuda S, Miki T, Mizobuchi K, Mori H, Motomura K, Nakamura Y, Nashimoto H, Nishio Y, Saito N, Horiuchi T, et al.: A 718-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 12.7-28.0 min region on the linkage map. DNA Res. 1996 Jun 30;3(3):137-55.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-62.
9384574	Matsuyama S, Yokota N, Tokuda H: A novel outer membrane lipoprotein, LolB (HemM), involved in the LolA (p20)-dependent localization of lipoproteins to the outer membrane of Escherichia coli. EMBO J. 1997 Dec 1;16(23):6947-55.

# Drug_Target_3_HGNC_ID:
Not Available

# Drug_Target_3_HPRD_ID:
Not Available

# Drug_Target_3_ID:
6805

# Drug_Target_3_Locus:
Not Available

# Drug_Target_3_Molecular_Weight:
23550.6

# Drug_Target_3_Name:
Outer-membrane lipoprotein lolB

# Drug_Target_3_Number_of_Residues:
207

# Drug_Target_3_PDB_ID:
1IWN

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF03550	LolB

# Drug_Target_3_Protein_Sequence:
>Outer-membrane lipoprotein lolB
MPLPDFRLIRLLPLAALVLTACSVTTPKGPGKSPDSPQWRQHQQDVRNLNQYQTRGAFAY
ISDQQKVYARFFWQQTGQDRYRLLLTNPLGSTELELNAQPGNVQLVDNKGQRYTADDAEE
MIGKLTGMPIPLNSLRQWILGLPGDATDYKLDDQYRLSEITYSQNGKNWKVVYGGYDTKT
QPAMPANMELTDGGQRIKLKMDNWIVK

# Drug_Target_3_Reaction:
Not Available

# Drug_Target_3_Signals:
1-21

# Drug_Target_3_Specific_Function:
Plays a critical role in the incorporation of lipoproteins in the outer membrane after they are released by the lolA protein. Essential for E.coli viability

# Drug_Target_3_SwissProt_ID:
P61320

# Drug_Target_3_SwissProt_Name:
LOLB_ECOLI

# Drug_Target_3_Synonyms:
Not Available

# Drug_Target_3_Theoretical_pI:
9.19

# Drug_Target_3_Transmembrane_Regions:
None

# Drug_Target_4_Cellular_Location:
Not Available

# Drug_Target_4_Chromosome_Location:
Not Available

# Drug_Target_4_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_4_Essentiality:
Essential

# Drug_Target_4_GenAtlas_ID:
Not Available

# Drug_Target_4_GenBank_ID_Gene:
AE007869

# Drug_Target_4_GenBank_ID_Protein:
15154859

# Drug_Target_4_GeneCard_ID:
Not Available

# Drug_Target_4_Gene_Name:
AGR_C_2535

# Drug_Target_4_Gene_Sequence:
>822 bp
GTGGAGAACAAAAAAAGCTTCTTCCATCTGCACCTGATTTCGGACTCGACGGGAGAGACT
CTGATGTCGGCCGGCCGCGCCGTCTCGGCGCAGTTTCATACATCCATGCCGGTGGAACAT
GTCTATCCGATGATCCGCAACCAGAAGCAGCTCGCGCAGGTCATCGATCTCATCGACAAG
GAGCCCGGCATTGTTCTTTATACAATCGTTGATCAGCAGCTGGCGGAATTCCTGGATCTG
CGCTGCCATGCGATTGGCGTGCCCTGCGTCAACGTTCTCGAACCGATCATCGGCATTTTC
CAGACCTATCTCGGCGCGCCGTCCAGGCGGCGGGTGGGTGCGCAACACGCGCTGAATGCC
GATTATTTCGCGCGGATCGAAGCACTCAATTTCGCCATGGACCATGATGACGGGCAGATG
CCGGAGACCTATGACGATGCGGATGTCGTCATCATCGGCATCAGCCGCACGTCGAAAACA
CCAACCAGCATCTATCTTGCTAACAGGGGCATAAAGACTGCCAATATCCCGGTCGTTCCC
AATGTGCCTTTGCCCGAAAGCCTATATGCCGCGACCCGGCCGTTGATCGTCGGTCTCGTC
GCGACATCGGATCGCATATCGCAGGTTCGTGAGAACAGGGATCTGGGTACAACCGGCGGA
TTTGACGGTGGCCGTTACACGGATCGCGCCACCATCATGGAAGAGCTGAAATATGCGCGT
GCGCTCTGCGCCCGCAACAATTGGCCGCTGATCGACGTCACACGCCGTTCCATCGAGGAA
ACGGCCGCGGCGATCCTTGCCCTGCGCCCGAGGACGCGATAA

# Drug_Target_4_General_Function:
Translation, ribosomal structure and biogenesis

# Drug_Target_4_General_References:
11743193	Wood DW, Setubal JC, Kaul R, Monks DE, Kitajima JP, Okura VK, Zhou Y, Chen L, Wood GE, Almeida NF Jr, Woo L, Chen Y, Paulsen IT, Eisen JA, Karp PD, Bovee D Sr, Chapman P, Clendenning J, Deatherage G, Gillet W, Grant C, Kutyavin T, Levy R, Li MJ, McClelland E, Palmieri A, Raymond C, Rouse G, Saenphimmachak C, Wu Z, Romero P, Gordon D, Zhang S, Yoo H, Tao Y, Biddle P, Jung M, Krespan W, Perry M, Gordon-Kamm B, Liao L, Kim S, Hendrick C, Zhao ZY, Dolan M, Chumley F, Tingey SV, Tomb JF, Gordon MP, Olson MV, Nester EW: The genome of the natural genetic engineer Agrobacterium tumefaciens C58. Science. 2001 Dec 14;294(5550):2317-23.
11743194	Goodner B, Hinkle G, Gattung S, Miller N, Blanchard M, Qurollo B, Goldman BS, Cao Y, Askenazi M, Halling C, Mullin L, Houmiel K, Gordon J, Vaudin M, Iartchouk O, Epp A, Liu F, Wollam C, Allinger M, Doughty D, Scott C, Lappas C, Markelz B, Flanagan C, Crowell C, Gurson J, Lomo C, Sear C, Strub G, Cielo C, Slater S: Genome sequence of the plant pathogen and biotechnology agent Agrobacterium tumefaciens C58. Science. 2001 Dec 14;294(5550):2323-8.

# Drug_Target_4_HGNC_ID:
Not Available

# Drug_Target_4_HPRD_ID:
Not Available

# Drug_Target_4_ID:
6806

# Drug_Target_4_Locus:
Not Available

# Drug_Target_4_Molecular_Weight:
16232.6

# Drug_Target_4_Name:
Putative uncharacterized protein

# Drug_Target_4_Number_of_Residues:
156

# Drug_Target_4_PDB_ID:
Not Available

# Drug_Target_4_Pathway:
Not Available

# Drug_Target_4_Pfam_Domain_Function:
PF01042	Ribonuc_L-PSP

# Drug_Target_4_Protein_Sequence:
>Putative uncharacterized protein
MSDVIEGRLKELGFTLPVAAAPAANYVPFTISGNLLYVSGQLPMESGKIAVTGLVGRDVD
VASAQRAAELCAVNILAQVKAALNGDLSKIRRVIKLNGFVASVPEFVEQHLVINGASNLI
ATVLGEPGRHARAAVGMASLPFNASVEIDAIVEIDV

# Drug_Target_4_Reaction:
Not Available

# Drug_Target_4_Signals:
None

# Drug_Target_4_Specific_Function:
Not Available

# Drug_Target_4_SwissProt_ID:
A9CJ63

# Drug_Target_4_SwissProt_Name:
A9CJ63_AGRT5

# Drug_Target_4_Synonyms:
Not Available

# Drug_Target_4_Theoretical_pI:
5.15

# Drug_Target_4_Transmembrane_Regions:
None

# Drug_Target_5_Cellular_Location:
Not Available

# Drug_Target_5_Chromosome_Location:
Not Available

# Drug_Target_5_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_5_Essentiality:
Essential

# Drug_Target_5_GenAtlas_ID:
Not Available

# Drug_Target_5_GenBank_ID_Gene:
AL590842

# Drug_Target_5_GenBank_ID_Protein:
115345833

# Drug_Target_5_GeneCard_ID:
cysE

# Drug_Target_5_Gene_Name:
cysE

# Drug_Target_5_Gene_Sequence:
>993 bp
ATGAAAAAACAATTTATCCAAAAACAACAACAAATCAGCTTCGTAAAATCATTCTTTTCC
CGCCAATTAGAGCAACAACTTGGCTTGATCGAAGTCCAGGCTCCTATTTTGAGCCGTGTG
GGTGATGGAACCCAAGATAACCTTTCTGGTTCTGAGAAAGCGGTACAGGTAAAAGTTAAG
TCATTGCCGGATTCAACTTTTGAAGTTGTACATTCATTAGCGAAGTGGAAACGTAAAACC
TTAGGGCGTTTTGATTTTGGTGCTGACCAAGGGGTGTATACCCATATGAAAGCATTGCGC
CCAGATGAAGATCGCCTGAGTGCTATTCATTCTGTATATGTAGATCAGTGGGATTGGGAA
CGGGTTATGGGGGACGGTGAACGTAACCTGGCTTACCTGAAATCGACTGTTAACAAGATT
TATGCAGCGATTAAAGAAACTGAAGCGGCGATCAGTGCTGAGTTTGGTGTGAAGCCTTTC
CTGCCGGATCATATTCAGTTTATCCACAGTGAAAGCCTGCGGGCCAGATTCCCTGATTTA
GATGCTAAAGGCCGTGAACGTGCAATTGCCAAAGAGTTAGGTGCTGTCTTCCTTATAGGG
ATTGGTGGCAAATTGGCAGATGGTCAATCCCATGATGTTCGTGCGCCAGATTATGATGAT
TGGACCTCTCCGAGTGCGGAAGGTTTCTCTGGATTAAACGGCGACATTATTGTCTGGAAC
CCAATATTGGAAGATGCCTTTGAGATATCTTCTATGGGAATTCGTGTTGATGCCGAAGCT
CTTAAGCGTCAGTTAGCCCTGACTGGCGATGAAGACCGCTTGGAACTGGAATGGCATCAA
TCACTGTTGCGCGGTGAAATGCCACAAACTATCGGGGGAGGTATTGGTCAGTCCCGCTTA
GTGATGTTATTGCTGCAGAAACAACATATTGGTCAGGTGCAATGTGGTGTTTGGGGCCCT
GAAATCAGCGAGAAAGTTGATGGCCTGCTGTAA

# Drug_Target_5_General_Function:
Amino acid transport and metabolism

# Drug_Target_5_General_References:
11586360	Parkhill J, Wren BW, Thomson NR, Titball RW, Holden MT, Prentice MB, Sebaihia M, James KD, Churcher C, Mungall KL, Baker S, Basham D, Bentley SD, Brooks K, Cerdeno-Tarraga AM, Chillingworth T, Cronin A, Davies RM, Davis P, Dougan G, Feltwell T, Hamlin N, Holroyd S, Jagels K, Karlyshev AV, Leather S, Moule S, Oyston PC, Quail M, Rutherford K, Simmonds M, Skelton J, Stevens K, Whitehead S, Barrell BG: Genome sequence of Yersinia pestis, the causative agent of plague. Nature. 2001 Oct 4;413(6855):523-7.

# Drug_Target_5_HGNC_ID:
Not Available

# Drug_Target_5_HPRD_ID:
Not Available

# Drug_Target_5_ID:
6807

# Drug_Target_5_Locus:
Not Available

# Drug_Target_5_Molecular_Weight:
29172.2

# Drug_Target_5_Name:
Serine acetyltransferase

# Drug_Target_5_Number_of_Residues:
273

# Drug_Target_5_PDB_ID:
Not Available

# Drug_Target_5_Pathway:
Not Available

# Drug_Target_5_Pfam_Domain_Function:
PF00132	Hexapep
PF06426	SATase_N

# Drug_Target_5_Protein_Sequence:
>Serine acetyltransferase
MSSEELEQVWSNIKSEARALAECEPMLASFFHATLLKHENLGSALSYILANKLANPIMPA
IAIREVVEEAYRSDAHMIVSAARDILAVRLRDPAVDKYSTPLLYLKGFHALQAYRIGHWL
WAQDRKALAIYLQNQVSVAFGVDIHPAATIGCGIMLDHATGIVIGETAVVENDVSILQSV
TLGGTGKTSGDRHPKIREGVMIGAGAKILGNIEVGRGAKIGAGSVVLQSVPAHTTAAGVP
ARIVGKPESDKPSLDMDQHFNGSIQGFEYGDGI

# Drug_Target_5_Reaction:
Not Available

# Drug_Target_5_Signals:
None

# Drug_Target_5_Specific_Function:
Not Available

# Drug_Target_5_SwissProt_ID:
Q0WKM4

# Drug_Target_5_SwissProt_Name:
Q0WKM4_YERPE

# Drug_Target_5_Synonyms:
Not Available

# Drug_Target_5_Theoretical_pI:
6.51

# Drug_Target_5_Transmembrane_Regions:
None

# Drug_Target_6_Cellular_Location:
Cell membrane. Present and active in lipid rafts

# Drug_Target_6_Chromosome_Location:
Not Available

# Drug_Target_6_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_6_Essentiality:
Non-Essential

# Drug_Target_6_GenAtlas_ID:
FYN

# Drug_Target_6_GenBank_ID_Gene:
M14333

# Drug_Target_6_GenBank_ID_Protein:
338228

# Drug_Target_6_GeneCard_ID:
FYN

# Drug_Target_6_Gene_Name:
FYN

# Drug_Target_6_Gene_Sequence:
>1614 bp
ATGGGCTGTGTGCAATGTAAGGATAAAGAAGCAACAAAACTGACGGAGGAGAGGGACGGC
AGCCTGAACCAGAGCTCTGGGTACCGCTATGGCACAGACCCCACCCCTCAGCACTACCCC
AGCTTCGGTGTGACCTCCATCCCCAACTACAACAACTTCCACGCAGCCGGGGGCCAAGGA
CTCACCGTCTTTGGAGGTGTGAACTCTTCGTCTCATACGGGGACCTTGCGTACGAGAGGA
GGAACAGGAGTGACACTCTTTGTGGCCCTTTATGACTATGAAGCACGGACAGAAGATGAC
CTGAGTTTTCACAAAGGAGAAAAATTTCAAATATTGAACAGCTCGGAAGGAGATTGGTGG
GAAGCCCGCTCCTTGACAACTGGAGAGACAGGTTACATTCCCAGCAATTATGTGGCTCCA
GTTGACTCTATCCAGGCAGAAGAGTGGTACTTTGGAAAACTTGGCCGAAAAGATGCTGAG
CGACAGCTATTGTCCTTTGGAAACCCAAGAGGTACCTTTCTTATCCGCGAGAGTGAAACC
ACCAAAGGGTCCTATTCACTTTCTATCCGTGATTGGGATGATATGAAAGGAGACCATGTC
AAACATTATAAAATTCGCAAACTTGACAATGGTGGATACTACATTACCACCCGGGCCCAG
TTTGAAACACTTCAGCAGCTTGTACAACATTACTCAGAGAGAGCTGCAGGTCTCTGCTGC
CGCCTAGTAGTTCCCTGTCACAAAGGGATGCCAAGGCTTACCGATCTGTCTGTCAAAACC
AAAGATGTCTGGGAAATCCCTCGAGAATCCCTGCAGTTGATCAAGAGACTGGGAAATGGG
CAGTTTGGGGAAGTATGGATGGGTACCTGGAATGGAAACACAAAAGTAGCCATAAAGACT
CTTAAACCAGGCACAATGTCCCCCGAATCATTCCTTGAGGAAGCGCAGATCATGAAGAAG
CTGAAGCACGACAAGCTGGTCCAGCTCTATGCAGTGGTGTCTGAGGAGCCCATCTACATC
GTCACCGAGTATATGAACAAAGGAAGTTTACTGGATTTCTTAAAAGATGGAGAAGGAAGA
GCTCTGAAATTACCAAATCTTGTGGACATGGCAGCACAGGTGGCTGCAGGAATGGCTTAC
ATCGAGCGCATGAATTATATCCATAGAGATCTGCGATCAGCAAACATTCTAGTGGGGAAT
GGACTCATATGCAAGATTGCTGACTTCGGATTGGCCCGATTGATAGAAGACAATGAGTAC
ACAGCAAGACAAGGTGCAAAGTTCCCCATCAAGTGGACGGCCCCCGAGCGAGCCCTGTAC
GGGAGGTTCACAATCAAGTCTGACGTGTGGTCTTTTGGAATCTTACTCACAGAGCTGGTC
ACCAAAGGAAGAGTGCCATACCCAGGCATGAACAACCGGGAGGTGCTGGAGCAGGTGGAG
CGAGGCTACAGGATGCCCTGCCCGCAGGACTGCCCCATCTCTCTGCATGAGCTCATGATC
CACTGCTGGAAAAAGGACCCTGAAGAACGCCCCACTTTTGAGTACTTGCAGAGCTTCCTG
GAAGACTACTTTACCGCGACAGAGCCCCAGTACCAACCTGGTGAAAACCTGTAA

# Drug_Target_6_General_Function:
Involved in protein kinase activity

# Drug_Target_6_General_References:
10790433	Brdicka T, Pavlistova D, Leo A, Bruyns E, Korinek V, Angelisova P, Scherer J, Shevchenko A, Hilgert I, Cerny J, Drbal K, Kuramitsu Y, Kornacker B, Horejsi V, Schraven B: Phosphoprotein associated with glycosphingolipid-enriched microdomains (PAG), a novel ubiquitously expressed transmembrane adaptor protein, binds the protein tyrosine kinase csk and is involved in regulation of T cell activation. J Exp Med. 2000 May 1;191(9):1591-604.
1699196	Peters DJ, McGrew BR, Perron DC, Liptak LM, Laudano AP: In vivo phosphorylation and membrane association of the fyn proto-oncogene product in IM-9 human lymphoblasts. Oncogene. 1990 Sep;5(9):1313-9.
3099169	Kawakami T, Pennington CY, Robbins KC: Isolation and oncogenic potential of a novel human src-like gene. Mol Cell Biol. 1986 Dec;6(12):4195-201.
3526330	Semba K, Nishizawa M, Miyajima N, Yoshida MC, Sukegawa J, Yamanashi Y, Sasaki M, Yamamoto T, Toyoshima K: yes-related protooncogene, syn, belongs to the protein-tyrosine kinase family. Proc Natl Acad Sci U S A. 1986 Aug;83(15):5459-63.
7664083	Musacchio A, Saraste M, Wilmanns M: High-resolution crystal structures of tyrosine kinase SH3 domains complexed with proline-rich peptides. Nat Struct Biol. 1994 Aug;1(8):546-51.
7687536	Noble ME, Musacchio A, Saraste M, Courtneidge SA, Wierenga RK: Crystal structure of the SH3 domain in human Fyn; comparison of the three-dimensional structures of SH3 domains in tyrosine kinases and spectrin. EMBO J. 1993 Jul;12(7):2617-24.
8394019	Prasad KV, Janssen O, Kapeller R, Raab M, Cantley LC, Rudd CE: Src-homology 3 domain of protein kinase p59fyn mediates binding to phosphatidylinositol 3-kinase in T cells. Proc Natl Acad Sci U S A. 1993 Aug 1;90(15):7366-70.
8681387	Lee CH, Saksela K, Mirza UA, Chait BT, Kuriyan J: Crystal structure of the conserved core of HIV-1 Nef complexed with a Src family SH3 domain. Cell. 1996 Jun 14;85(6):931-42.
8805554	Morton CJ, Pugh DJ, Brown EL, Kahmann JD, Renzoni DA, Campbell ID: Solution structure and peptide binding of the SH3 domain from human Fyn. Structure. 1996 Jun 15;4(6):705-14.
8961927	Renzoni DA, Pugh DJ, Siligardi G, Das P, Morton CJ, Rossi C, Waterfield MD, Campbell ID, Ladbury JE: Structural and thermodynamic characterization of the interaction of the SH3 domain from Fyn with the proline-rich binding site on the p85 subunit of PI3-kinase. Biochemistry. 1996 Dec 10;35(49):15646-53.
9351806	Mulhern TD, Shaw GL, Morton CJ, Day AJ, Campbell ID: The SH2 domain from the tyrosine kinase Fyn in complex with a phosphotyrosyl peptide reveals insights into domain stability and binding specificity. Structure. 1997 Oct 15;5(10):1313-23.

# Drug_Target_6_HGNC_ID:
HGNC:4037

# Drug_Target_6_HPRD_ID:
00655

# Drug_Target_6_ID:
934

# Drug_Target_6_Locus:
6q21

# Drug_Target_6_Molecular_Weight:
60631

# Drug_Target_6_Name:
Proto-oncogene tyrosine-protein kinase Fyn

# Drug_Target_6_Number_of_Residues:
536

# Drug_Target_6_PDB_ID:
Not Available

# Drug_Target_6_Pathway:
Not Available

# Drug_Target_6_Pfam_Domain_Function:
PF00017	SH2
PF00018	SH3_1
PF07714	Pkinase_Tyr

# Drug_Target_6_Protein_Sequence:
>Proto-oncogene tyrosine-protein kinase Fyn
GCVQCKDKEATKLTEERDGSLNQSSGYRYGTDPTPQHYPSFGVTSIPNYNNFHAAGGQGL
TVFGGVNSSSHTGTLRTRGGTGVTLFVALYDYEARTEDDLSFHKGEKFQILNSSEGDWWE
ARSLTTGETGYIPSNYVAPVDSIQAEEWYFGKLGRKDAERQLLSFGNPRGTFLIRESETT
KGAYSLSIRDWDDMKGDHVKHYKIRKLDNGGYYITTRAQFETLQQLVQHYSERAAGLCCR
LVVPCHKGMPRLTDLSVKTKDVWEIPRESLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTL
KPGTMSPESFLEEAQIMKKLKHDKLVQLYAVVSEEPIYIVTEYMNKGSLLDFLKDGEGRA
LKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEYT
ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER
GYRMPCPQDCPISLHELMIHCWKKDPEERPTFEYLQSFLEDYFTATEPQYQPGENL

# Drug_Target_6_Reaction:
ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate

# Drug_Target_6_Signals:
None

# Drug_Target_6_Specific_Function:
Implicated in the control of cell growth

# Drug_Target_6_SwissProt_ID:
P06241

# Drug_Target_6_SwissProt_Name:
FYN_HUMAN

# Drug_Target_6_Synonyms:
EC 2.7.10.2
Protooncogene Syn
SLK
p59-Fyn

# Drug_Target_6_Theoretical_pI:
6.65

# Drug_Target_6_Transmembrane_Regions:
None

# Drug_Target_7_Cellular_Location:
Mitochondrion
mitochondrial matrix

# Drug_Target_7_Chromosome_Location:
Not Available

# Drug_Target_7_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_7_Essentiality:
Non-Essential

# Drug_Target_7_GenAtlas_ID:
PPIF

# Drug_Target_7_GenBank_ID_Gene:
M80254

# Drug_Target_7_GenBank_ID_Protein:
181274

# Drug_Target_7_GeneCard_ID:
PPIF

# Drug_Target_7_Gene_Name:
PPIF

# Drug_Target_7_Gene_Sequence:
>624 bp
ATGCTGGCGCTGCGCTGCGGCTCCCGCTGGCTCGGCCTGCTCTCCGTCCCGCGCTCCGTG
CCGCTGCGCCTCCCCGCGGCCCGCGCCTGCAGCAAGGGCTCCGGCGACCCGTCCTCTTCC
TCCTCCTCCGGGAACCCGCTCGTGTACCTGGACGTGGACGCCAACGGGAAGCCGCTCGGC
CGCGTGGTGCTGGAGCTGAAGGCAGATGTCGTCCCAAAGACAGCTGAGAACTTCAGAGCC
CTGTGCACTGGTGAGAAGGGCTTCGGCTACAAAGGCTCCACCTTCCACAGGGTGATCCCT
TCCTTCATGTGCCAGGCGGGCGACTTCACCAACCACAATGGCACAGGCGGGAAGTCCATC
TACGGAAGCCGCTTTCCTGACGAGAACTTTACACTGAAGCACGTGGGGCCAGGTGTCCTG
TCCATGGCTAATGCTGGTCCTAACACCAACGGCTCCCAGTTCTTCATCTGCACCATAAAG
ACAGACTGGTTGGATGGCAAGCATGTTGTGTTCGGTCACGTCAAAGAGGGCATGGACGTC
GTGAAGAAAATAGAATCTTTCGGCTCTAAGAGTGGGAGGACATCCAAGAAGATTGTCATC
ACAGACTGTGGCCAGTTGAGCTAA

# Drug_Target_7_General_Function:
Posttranslational modification, protein turnover, chaperones

# Drug_Target_7_General_References:
1744118	Bergsma DJ, Eder C, Gross M, Kersten H, Sylvester D, Appelbaum E, Cusimano D, Livi GP, McLaughlin MM, Kasyan K, et al.: The cyclophilin multigene family of peptidyl-prolyl isomerases. Characterization of three separate human isoforms. J Biol Chem. 1991 Dec 5;266(34):23204-14.

# Drug_Target_7_HGNC_ID:
HGNC:9259

# Drug_Target_7_HPRD_ID:
06839

# Drug_Target_7_ID:
2554

# Drug_Target_7_Locus:
10q22-q23

# Drug_Target_7_Molecular_Weight:
22040

# Drug_Target_7_Name:
Peptidyl-prolyl cis-trans isomerase, mitochondrial

# Drug_Target_7_Number_of_Residues:
207

# Drug_Target_7_PDB_ID:
2BIU

# Drug_Target_7_Pathway:
Not Available

# Drug_Target_7_Pfam_Domain_Function:
PF00160	Pro_isomerase

# Drug_Target_7_Protein_Sequence:
>Peptidyl-prolyl cis-trans isomerase, mitochondrial precursor
MLALRCGSRWLGLLSVPRSVPLRLPAARACSKGSGDPSSSSSSGNPLVYLDVDANGKPLG
RVVLELKADVVPKTAENFRALCTGEKGFGYKGSTFHRVIPSFMCQAGDFTNHNGTGGKSI
YGSRFPDENFTLKHVGPGVLSMANAGPNTNGSQFFICTIKTDWLDGKHVVFGHVKEGMDV
VKKIESFGSKSGRTSKKIVITDCGQLS

# Drug_Target_7_Reaction:
peptidylproline (omega=180) = peptidylproline (omega=0)

# Drug_Target_7_Signals:
None

# Drug_Target_7_Specific_Function:
PPIases accelerate the folding of proteins. It catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides

# Drug_Target_7_SwissProt_ID:
P30405

# Drug_Target_7_SwissProt_Name:
PPIF_HUMAN

# Drug_Target_7_Synonyms:
Cyclophilin F
EC 5.2.1.8
PPIase
Peptidyl-prolyl cis-trans isomerase, mitochondrial precursor
Rotamase

# Drug_Target_7_Theoretical_pI:
9.95

# Drug_Target_7_Transmembrane_Regions:
None

# Drug_Target_8_Cellular_Location:
Cytoplasmic

# Drug_Target_8_Chromosome_Location:
Not Available

# Drug_Target_8_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_8_Essentiality:
Essential

# Drug_Target_8_GenAtlas_ID:
Not Available

# Drug_Target_8_GenBank_ID_Gene:
AE017194

# Drug_Target_8_GenBank_ID_Protein:
42734997

# Drug_Target_8_GeneCard_ID:
Not Available

# Drug_Target_8_Gene_Name:
BCE_3424

# Drug_Target_8_Gene_Sequence:
>1341 bp
TTGGAAAACATCTCTGATTTATGGAACAGCGCCTTAAAAGAACTAGAAAAAAAGGTCAGT
AAACCAAGCTATGAAACATGGTTAAAATCAACGACCGCACATAATTTAAAGAAAGATGTA
TTAACAATTACGGCTCCAAATGAATTCGCCCGCGATTGGCTAGAATCTCATTATTCAGAG
CTAATTTCGGAAACACTTTATGATTTAACAGGGGCAAAACTAGCTATTCGCTTTATTATT
CCCCAAAGTCAAGCTGAAGAGGAGATCGATCTTCCTCCTTCTAAACCGAATTCAGCACAA
GATGATTCTAATCATTTACCACAGAGTATGCTAAATCCAAAATATACGTTTGATACGTTT
GTTATTGGCTCTGGTAACCGTTTTGCTCACGCTGCTTCATTGGCCGTAGCCGAAGCGCCA
GCTAAAGCATATAATCCCCTCTTTATTTATGGGGGAGTTGGACTTGGAAAGACCCATTTA
ATGCATGCAATTGGTCATTATGTAATTGAACATAACCCAAATGCCAAAGTTGTATATTTA
TCATCAGAAAAATTTACAAATGAATTTATTAATTCTATTCGTGATAATAAAGCAGTCGAT
TTTCGTAATAAATACCGCAATGTAGATGTTTTATTGATAGATGATATTCAATTTTTAGCG
GGAAAAGAACAAACTCAAGAAGAGTTTTTCCATACATTCAATGCATTACACGAAGAAAGT
AAACAAATTGTAATTTCCAGTGATCGGCCACCAAAAGAAATTCCAACTTTAGAAGATCGT
CTTCGTTCTCGCTTTGAATGGGGACTCATTACGGATATTACGCCACCAGATTTAGAAACA
CGAATTGCAATTTTGCGCAAAAAAGCAAAGGCTGAAGGACTTGATATACCAAATGAGGTC
ATGCTTTATATTGCAAATCAAATCGATTCAAATATTCGTGAACTAGAAGGTGCACTCATC
CGAGTTGTAGCTTATTCATCTTTAATTAATAAAGATATTAATGCTGATTTAGCAGCTGAA
GCACTTAAAGATATTATTCCAAATTCTAAACCAAAAATTATCTCCATTTATGATATTCAA
AAAGCTGTCGGAGATGTTTATCAAGTAAAATTGGAAGATTTCAAGGCGAAAAAGCGAACG
AAATCAGTTGCCTTTCCTCGCCAAATTGCAATGTATTTATCACGTGAACTGACAGACTCC
TCCTTACCTAAAATAGGTGAAGAATTCGGTGGACGCGATCATACAACCGTTATCCATGCT
CATGAAAAAATTTCTAAGCTACTTAAGACGGACACGCAATTACAAAAGCAAGTTGAAGAA
ATTAACGATATTTTAAAGTAG

# Drug_Target_8_General_Function:
Transcription

# Drug_Target_8_General_References:
14960714	Rasko DA, Ravel J, Okstad OA, Helgason E, Cer RZ, Jiang L, Shores KA, Fouts DE, Tourasse NJ, Angiuoli SV, Kolonay J, Nelson WC, Kolsto AB, Fraser CM, Read TD: The genome sequence of Bacillus cereus ATCC 10987 reveals metabolic adaptations and a large plasmid related to Bacillus anthracis pXO1. Nucleic Acids Res. 2004 Feb 11;32(3):977-88. Print 2004.

# Drug_Target_8_HGNC_ID:
Not Available

# Drug_Target_8_HPRD_ID:
Not Available

# Drug_Target_8_ID:
6808

# Drug_Target_8_Locus:
Not Available

# Drug_Target_8_Molecular_Weight:
27781.9

# Drug_Target_8_Name:
Transcriptional regulator, GntR family

# Drug_Target_8_Number_of_Residues:
245

# Drug_Target_8_PDB_ID:
Not Available

# Drug_Target_8_Pathway:
Not Available

# Drug_Target_8_Pfam_Domain_Function:
PF00392	GntR
PF07702	UTRA

# Drug_Target_8_Protein_Sequence:
>Transcriptional regulator, GntR family
MASGSTQVKYLGIYQKMKQQILDGEYKINEKIPSSPILAEEFGVSVLTIKKALDLLVRDG
YIIRRRGSGTVVQDWRQQEKARMIQTLTGTKAVYGSEVESKIIEFTIVGADEIIAEKLGI
SVGDFVYKIIRLRIIHSIPTIMEHTWMPIAVIPGVEASVLEESIYSYIQNKLGLKVGTSV
VRVKGIRPDDKEKQFMNLTNQDFLMRVEQVAYLTDGRTFEYSYADHLPETFEFETVITAK
SYKEA

# Drug_Target_8_Reaction:
Not Available

# Drug_Target_8_Signals:
None

# Drug_Target_8_Specific_Function:
Not Available

# Drug_Target_8_SwissProt_ID:
Q734I1

# Drug_Target_8_SwissProt_Name:
Q734I1_BACC1

# Drug_Target_8_Synonyms:
Not Available

# Drug_Target_8_Theoretical_pI:
6.82

# Drug_Target_8_Transmembrane_Regions:
None

# Drug_Target_9_Cellular_Location:
Not Available

# Drug_Target_9_Chromosome_Location:
Not Available

# Drug_Target_9_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_9_Essentiality:
Essential

# Drug_Target_9_GenAtlas_ID:
Not Available

# Drug_Target_9_GenBank_ID_Gene:
CP000031

# Drug_Target_9_GenBank_ID_Protein:
56676666

# Drug_Target_9_GeneCard_ID:
Not Available

# Drug_Target_9_Gene_Name:
SPO2066

# Drug_Target_9_Gene_Sequence:
>1869 bp
GTGAAACATTCGGATTTCGATATTGTCGTGATCGGGGCCGGACATGCCGGCGCCGAGGCT
GCACATGCTGCGGCACGCATGGGAATGCGTACTGCCTTGGTTTCCCTGTCCGAACGCGAC
ATTGGCGTGATGTCCTGTAACCCGGCTATTGGCGGTTTGGGTAAGGGGCATCTGGTTCGC
GAGATCGACGCACTTGACGGGGTCATGGGGCGGGTGGCCGACAAGGCCGGGATTCAATTT
CGTCTGCTCAATCGGCGCAAGGGTCCTGCGGTCCAGGGGCCGCGCGCTCAGGCCGATCGC
AAGCTCTATCGCCTGGCGATGCAGGAAGAAATGCGCAATCGCCCCGGACTGACCATCGTC
GAGGGCGAGGTTACTGATTTTCGAATGCAAGGTGATCGCGTTGCCGGCGTCGTTCTGGCC
GATGGGTCCGAGATTGCATCGCAAGCCGTGATCTTGACCTCGGGCACGTTCCTGCGCGGG
ATCATTCATATTGGCGATGTTTCGCGCCCCGGTGGGCGGATGGGTGACCGACCTTCAGTT
CCGCTTGCCGAAAGGCTGGATGGATTTGCGTTACCGATGGGGCGACTAAAGACCGGAACG
CCGCCGCGACTGGACGGACGCACCATAGACTGGTCTATCCTCGAGCGTCAGGACGGGGAT
GACGATCCGGTGCTGTTCTCGTTCCTGTCAAAAGGGGCCTATGCGCGTCAGATCGCCTGC
GGTATCACGCATACCAACGCCCAGACGCATGAGATCATTCGCAAAAACCTGTCCCGTTCC
GCGATGTATGGCGGACATATCGAAGGCGTCGGCCCTCGTTACTGCCCCTCGATCGAGGAC
AAAATCGTGCGTTTCGCTGACAAGGATTCGCATCAGATCTTTCTTGAGCCCGAGGGGCTG
GAAGATCACACTGTCTATCCGAACGGTATCTCGACCTCGTTGCCGGTCGACGTGCAAGAG
GACTATGTCCGTTCGATCCGGGGGCTGGAACAGGTTGAGATCTTGCAGCCCGGTTACGCG
ATCGAATACGACTATGTTGATCCCCGCGCGCTCACGTCGCAACTGTCTCTGCCGAATGTT
CCGGGCTTGTACCTAGCCGGTCAGATCAATGGAACAACCGGGTATGAAGAGGCTGCGGCG
CAGGGAATGGTTGCCGGGTTGAACGCAGCCACCGCGATTTTGGGTCACGAACCGGTCCCC
TTCAGTCGTGCCAACAGCTATATCGGTGTGATGATCGACGATCTGACCACACGCGGTGTG
GCAGAGCCCTATCGCATGTTCACCTCGCGGGCCGAATTCCGCCTGTCCTTGCGTGCGGAT
AACGCGGATCAGCGGCTGACGCCCTTGGGATTGGAATTGGGTTGTGTCGGTGACGAACGG
CGCGACGTCTTTGCGCGTAAGGCAGAGAAACTGGCGACAGCCTCGGCGCTGCTCGATCAG
AGCAGCTTTAGCCCCAAAGAGATTGCCACAGCTGGTATCACCATCAGTCAGGACGGCAAT
CGGAGAAACGGCTTCGCTGTCCTCGCCTTTCCGGACGTCAGGTTTGACGACCTTGTGCCA
CTAATCCCGGAACTTGCAGACACCGACGCCGAAACCCGCGCGCAGGTAGAGCGTGATGCG
CTTTATGCCAATTACATCGCGCGGCAGGAACGGGATGTTGAGGCGATGAAACGGGATGAG
GCGCTGGTCATTCCGATCGACTTCAACTTTTCTGCCCTCGATGGGTTGTCAAATGAGTTG
AAGCAAAAACTCACATCCGCGCGACCGGAAAATATCGCGCAGGCCGGGCGTGTTGAGGGG
ATGACGCCAGCGGCGCTTGCGCTCATCCTGGCCCGCCTTCGCCGTGGCGACCGAGCACGA
AGCGCATGA

# Drug_Target_9_General_Function:
Amino acid transport and metabolism

# Drug_Target_9_General_References:
15602564	Moran MA, Buchan A, Gonzalez JM, Heidelberg JF, Whitman WB, Kiene RP, Henriksen JR, King GM, Belas R, Fuqua C, Brinkac L, Lewis M, Johri S, Weaver B, Pai G, Eisen JA, Rahe E, Sheldon WM, Ye W, Miller TR, Carlton J, Rasko DA, Paulsen IT, Ren Q, Daugherty SC, Deboy RT, Dodson RJ, Durkin AS, Madupu R, Nelson WC, Sullivan SA, Rosovitz MJ, Haft DH, Selengut J, Ward N: Genome sequence of Silicibacter pomeroyi reveals adaptations to the marine environment. Nature. 2004 Dec 16;432(7019):910-3.

# Drug_Target_9_HGNC_ID:
Not Available

# Drug_Target_9_HPRD_ID:
Not Available

# Drug_Target_9_ID:
6809

# Drug_Target_9_Locus:
Not Available

# Drug_Target_9_Molecular_Weight:
67355.2

# Drug_Target_9_Name:
ABC transporter, periplasmic substrate-binding protein

# Drug_Target_9_Number_of_Residues:
604

# Drug_Target_9_PDB_ID:
Not Available

# Drug_Target_9_Pathway:
Not Available

# Drug_Target_9_Pfam_Domain_Function:
PF00496	SBP_bac_5

# Drug_Target_9_Protein_Sequence:
>ABC transporter, periplasmic substrate-binding protein
MRPDYFRPFRPLTAGIALLLGASFADAESRHAIAMYGAPALPPDFVSLPYANPDAPKGGR
VVFGNTGGFDSLNPFAQKGTFPWQMPFWSYESLMGRSWDEPFTLYGLLAESVEVPPDRAW
VEFTLREEARFSDGSPVTVEDVIWSYQTLGTEGHLRYRGFWSRIASIEATGPRSLRITFA
DEDRELAMLAGLRPILQKAQWEGRSLSEGNIHDIPIGTGPYVVSAYEPGRYVTFARNPDY
WGADLGFRRGTMNFDEMRIDFFGDGTVLMEAFKAGELSAIREFNAQKWDSAYDFPAAQRG
DVIKTEIAHGKPSGMTGFVINTRRAPFDDWRLREALLLAFNFEFINDTVTGGVMPRITSY
FSGTDLAYRPGTASGREAELLAPFAADLPPGTLEGYALPQGDGTARNRTNLRRAAQFLEQ
AGFRIEQGQLLGPDGAPLALRFLLRQGDSDMQTVLEIYTRALERLGIAAQIEKVDNAQYT
ARVAELDFDLTPFRRDLSLSPGNEQRLYWGSHSAGQPGTRNLMGAASPAIDAMIDRMLAA
TTEDELTAATRALDRVLTAGRYVIPIWRFDVGRIAHIRQLRFPPNPPIYGDGPQYMPDVW
WYQD

# Drug_Target_9_Reaction:
Not Available

# Drug_Target_9_Signals:
None

# Drug_Target_9_Specific_Function:
Not Available

# Drug_Target_9_SwissProt_ID:
Q5LRQ9

# Drug_Target_9_SwissProt_Name:
Q5LRQ9_SILPO

# Drug_Target_9_Synonyms:
Not Available

# Drug_Target_9_Theoretical_pI:
4.87

# Drug_Target_9_Transmembrane_Regions:
None

#END_DRUGCARD DB02078
